Elixinol Wellness Limited
ELLXF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | -0.00 | 0.06 | 0.17 |
| FCF Yield | -51.06% | -28.60% | -6.99% | -2.63% |
| EV / EBITDA | -1.66 | -2.59 | -14.38 | -22.33 |
| Quality | ||||
| ROIC | -18.57% | 8.61% | -22.55% | -37.17% |
| Gross Margin | 34.60% | 39.42% | 35.68% | -13.94% |
| Cash Conversion Ratio | 0.45 | -0.48 | 0.78 | 0.52 |
| Growth | ||||
| Revenue 3-Year CAGR | -2.42% | -18.05% | -23.29% | -32.06% |
| Free Cash Flow Growth | -4.26% | 38.86% | -1.39% | -251.22% |
| Safety | ||||
| Net Debt / EBITDA | -0.71 | -0.40 | 0.18 | -0.15 |
| Interest Coverage | -8.61 | -28.30 | -29.77 | -39.67 |
| Efficiency | ||||
| Inventory Turnover | 1.73 | 1.27 | 1.07 | 1.50 |
| Cash Conversion Cycle | 27.94 | 55.31 | 67.64 | 63.14 |